Author:
Candelise L.,Roncaglioni C.,Aritzu E.,Ciccone A.,Maggioni A. P.,
Publisher
Springer Science and Business Media LLC
Subject
Neurology (clinical),General Neuroscience,Psychiatry and Mental health,Neurology (clinical),Dermatology,General Medicine
Reference134 articles.
1. Abe T., Terashi A., Tohgi H. et al.:Clinical efficacy of intravenous administration of SM-9527 (tPA) in cerebral thrombosis. Clin. Eval., 18: 36–69, 1990.
2. Anderson V., Willerson J.T. Thrombolysis in acute myocardial infarction. Curr. Concepts, 329, 10: 703–709, 1993.
3. Anglo-Scandinavian Study of Early thrombolysis (ASSET):Trial of tissue plasminogen activator for mortality reduction in acute myocardial infarction. Lancet, ii: 525–530, 1988.
4. Ardissino D., Barberis P., De Servi S. et al.:Recombinant tissue-type plasminogen activator followed by heparin compared with heparin alone for refractory unstable angina pectoris. Am. J. Cadiol. 66: 910–914, 1990.
5. Baird A.E., Donnan G.A., Austin M.C., Fitt G.J., McKay W.J.:HMPAO SPECT measures reperfusion after thrombolytic therapy in acute stroke. In: Del Zoppo G.J., Mori E., Hacke W. (Eds.):Thrombolytic therapy in acute ischemic stroke, Springer-Verlag Berlin Heidelberg, pp. 301–303, 1993.
Cited by
5 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献